Clinical Haemostasis Flashcards

(42 cards)

1
Q

What is haemostasis?

A

Process of minimising blood loss during injury, blood clotting.
5 systems keep blood in liquid state:
Vascular
Platelets
Coagulation Cascade
Inhibitors of coagulation
Fibrinolytic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Vascular System in Haemostasis

A

Upon damage, lumen of vessel narrows minimising flow of blood through, decreasing blood lost, bacteria cannot get in, blood pressure drops so platelets can anchor.

Vasoconstriction.
Adrenaline, ADP and thromboxanes regulate, when released by platelets (also serotonin)

Endothelial cells source of pro and anti-thrombotic compounds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anti-coagulant aspect of endothelial cells

A

Glycated muco polysaccharideshave heparin sulphate on surface, slows formation of blood clots.
Keep pro aspect of of coagulation in inactive form.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pro-thormbotic aspect of endothelial cells

A

Piercing of tunica media releases pro thrombotic factors it contains, collagen, tissue factor, activate coagulation cascade.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Blood Platelets

A

-Precursor is mega karyocyte which sheds platelets that do not have a nucleus or some organelles.
-Release alpha (200 per/cell) and dense granules (10 per/cell)
[peptides, signal molecules that encourage formation of blood clots]
[3rd granule is lysosome which maintains cell environment]
-Canalicular System releases granules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do platelets release?

A

Alpha and dense granules.
-ADP (mitochondria), adrenaline, serotonin, factor 5 and Von Willerbrand’s factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Function of platelets?

A

-platelet plug (transiently attached)
-temporary physical barrier to prevent blood loss (primary homeostasis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

4 Phases of primary homeostasis, formation of platelet plug?

A

1) Platelet adhesion (to site of damage)
2) Platelet activation
3) Release of platelet granules
4) Platelet adhesion

(veins and arteriole’s high pressure can wash plugs away)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are platelets adhesion activated?

A

Upon contact with Collagen, Charged surface, Bacterial endotoxin (exposed in damaged vessel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Von Willebrand’s Factor Function?

A

Aids platelet adhesion.
-Large multimeric glycoprotein
produced by platelets and
endothelium.
-Binds to GPIb receptor on platelets
encouraging adhesion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Platelet Shape Change

A

-Once bound to a substrate platelets become activated and change their morphology.
-Discoid shape to ameboid.
-Circular shape would leave gaps, ameboid has finger like projections maximising surface area.
-Here granules start migrating to canalicular system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Release of platelet granules?

A
  • Ca2+ mediated fusion of the granules with the canalicular system. [ Ca2+ stored in mitochondria, also released to interstitial fluid for haemostasis]
    -Promotes vasoconstriction
    -Promoting platelet adhesion (Amplification of adhesion events)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Platelet aggregation?

A

-Activation of platelets results in platelet GPIIb receptors binding fibrinogen. This results in formation of inter-platelet bridge.
-ADP released from damaged cells and granules allows for self-propagation of platelet aggregation
-End point is primary haemostatic plug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Secondary Haemostasis

A

-For bigger wounds
-Proper blood coagulation beginning on top of platelet plug.
-Plasma proteins convert soluble fibrinogen to insoluble fibrin (inactive enzymes zymogens and cofactors (proteolytic)
-fibrinogen produced in liver (acute phase reactant)
(most plasma proteins are produced in the liver and that is why liver disease is associated with bleeding)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Coagulation Factors

A

Named now 1 to 13 roman numerals.
-4 is calcium
-3 is tissue factor
-1 is substate (fibrinogen)
Many are serine proteases (horse shoe crab contamination test)
-Factor 13, fibrin stabilising factor is transglutaminase, links peptides together,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Vitamin K

A

-Fat soluble requires lipases for absorption from pancreas, essential to haemostasis.
-breaks down clots too
-Uses carboxylation to activate several pro and anti coagulants (2,7,9,10)
-Once activated factors bind Ca2+

V.K carboxylase epoxidase uses V.K as cofactor for carboxylation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Warfarin (anticoagulant)

A

-treats thrombo-embolic disease.
-inhibits Vitamin K carboxylase epoxidase
-rat poison

(dosing closely monitored genetic variation in enzyme metabolism, too high, spontaneous haemorrhaging)

International normalized ration 2-3 best above 3 emergency.

18
Q

Intrinsic pathway of coagulation cascade

A

Surface contact (initiation) (charged environment)
F12- F12a
F11-F11a
F9-F9a (activates F10)
(a’s are active enzyme start as zymogen)

19
Q

Extrinsic Pathway of coagulation cascade

A

Tissue damage (initiation)
Tissue factor (TF) and F7 complex. (activates F10)

20
Q

Common Pathway of coagulation cascade

A

F10-F10a
Prothrombin to thrombin converts
F13-F13a and
Fibrinogen to fibrin.
Stable cut

21
Q

Testing Intrinsic and Extrinsic Pathway for Coagulation?

A

Intrinsic=activated partial thromboplastin time. (kaolin, charged silicat activation)
Extrinsic=prothrombin time (add tissue factor)

22
Q

Haemophilia A

A
  • X linked recessive disorder (1/5000 males)
    -F8 deficiency (cofactor for F9)
    -intrinsic tenase complex formed with F9 activates F10.
23
Q

Haemophilia B

A

1/30000 males, 15% of all cases.
- B caused by a deficiency in F9.

24
Q

Female haemophilia

A

Very rare,
-Turner’s Syndrome
-Homozygous for F8 Deficiency
-Inappropriate lyonization

25
Clinical Presentation of Haemophilia
-Haematuria (blood in urine) -Purpura -Bruising -Epistaxis (nose bleeds) Haemorrhage -Hemarthrosis (synovial joint bleeding, arthritis, immune complexes)
26
Treatment of Haemophilia
-Recombinant FVIII or FIX (tissue culture techniques) -Clotting factor concentrates - Cryoprecipitate -Blood plasma (historic, problematic blood bone infections)
27
Fibrinogen
-Hepatocytes (3g/L in humans) -Symmetrical hexamer (3 chain) -cleaved by thrombin into fibrin [weak linear fibrin strands, so transglutaminase cross links D-domains] [D-dimer is biomarker of clot, stays for long time, stroke indicator (deep vein thrombosis) or pulmonary embolism]
28
Regulation of Secondary Haemostasis
-Exposure of TF localises -Antithrombin -heparin -Protein C and S -Factor V leiden -Fibrinolysis (plasmin)
29
Antithrombin (3)
- small glycoprotein (432 a.a) from liver (disease can cause too many clots) -inhibitor of serine protease coagulation factors (FIXa. FXa, FXIa, TF:FVIIa, thrombin) -Forms stable 1:1 complexes with target enzymes -Binds to heparin sulphate on cell surfaces which it requires as a co-factor
30
Heparin (anticoagulant)
-A heterogenous mix of sulphated mucopolysaccharides. High molecular weight or low molecular weight prescriptions. -High increases activity of antithrombin 3 by 1000 fold -low inhibits F10a (pharmacological target part of common pathway) (its too good needs to be very closely monitored or can cause haemorrhage)
31
Protein C and S
Vit K dependent zymogen that deactivates F5a and F8a. -Protein C is activated by binding to thrombin. -Cleaves F5a in 3 places ARG306, 506, 679 -cofactors required are FV and Protein S -Protien S, V.K dependant factor -binds strongly to charged surface of platelets, forms calcium ion complex with activated protein C (APC)
32
Factor V Leiden
-Mutation in F5 gene. -F5 essential cofactor for F10a -Activated Protein C degrades F5. -SNP mutation causes arginine to gluatmine mutation at 506. -FVL mutation causes resistance to aPC [More spontaneous blood clots]
33
Epidemiology of FVL
-most common thrombotic disorder -5% of white people -Heterozygous carrier 8 times risk of deep vein thrombosis (homozygous 100X -autosomal dominant inheritance [survival trait]
34
Risk factor for FVL
Smoking, not moving for long periods (venous stasis)(sitting) Contraceptive pill (oestrogen) (doubly increases risk)
35
Fibrinolysis
Proteolytic enzymes -Prevent vascular occlusion -Removal of clot as part of tissue remodelling process
36
Plasmin
Activated plasminogen. -plasminogen glycoprotein from liver -cleaved by tissue plasminogen activator into plasmin -5 Kringle domains which enable fibrin binding
37
Regulation of Plasmin
-Plasminogen activation occurs as soon as 2ndary homeostasis begins -serine proteases from coagulation cascade activate plasminogen (factor 11a, 12a, kallikrein]
38
Fibrin Degradation Products
-plasmin degrades -D-dimer, used diagnostically for deep vein thrombosis, pulmonary emboli (higher D-dimer more likely a thrombotic event has occurred) (negative for D-dimer but clinical manifestation of stroke could mean haemorrhagic stroke)
39
Disseminated Intravascular Coagulation
-an acquired bleeding disorder -many disorders contribute -widespread acitvation of coagulation cascade -microthrombi -haemorrhage, due to consumption of coagulation factors
40
Conditions Associated with DIC
-Obstetric complications =abruptio =aminotic =retained fetus =septic abortion =eclampsia Malignancy Infections -lipopolysaccharides -trauma liver disease anaphylactic shock snake bites (Russel pit viper)
41
Pathogenesis of DIC
Trigger activates coagulation. Platelets aggregate, fibrin deposition, activation of fibrinolysis. Microthrombi form, Depletion of coagulation factors, thrombocytopenia. Haemorrhage
42
Treatment of DIC
Platelet infusions Cryoprecipitate Clotting Factors Treat underlying cause: antibiotics chemotherapy anti venom delivery of baby